Sterling Capital Management
VOR icon

Sterling Capital Management’s Vor Biopharma VOR Stock Holding History

Sterling Capital Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.1K Buy
1,107
+752
+212% +$16.1K ﹤0.01% 2166
2026
Q2 		$6.54K Buy
+355
New +$5.37K ﹤0.01% 2469

Other funds holding VOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
NEXTBio Capital Management
NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Axiom Investors
Axiom Investors Greenwich, Connecticut $14B AUM 51.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Sterling Capital Management's VOR Position: Q3 2026 in Review

Sterling Capital Management increased its Vor Biopharma (VOR) stake by 212% in Q3 2026, buying an estimated $16.1K and bringing the position to 1,107 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Sterling Capital Management first reported a position in VOR in Q2 2026 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Sterling Capital Management held 1,107 shares of Vor Biopharma worth $21.1K as of Q3 2026.
  • Sterling Capital Management bought 752 Vor Biopharma shares in Q3 2026, an estimated $16.1K.
  • Vor Biopharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2166 holding.
  • Sterling Capital Management first reported a position in Vor Biopharma in Q2 2026 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.